The emerging role of prostate-specific membrane antigen-targeted radioligand therapy in metastatic hormone-sensitive prostate cancer. - Mulugeta P; Dorff T; Hafron J; Huynh MA; Morgans AK; Ross AE; McKay RR (The oncologist, 2026)